ATE99925T1 - Verfahren zur herstellung eines ranitidin-harzabsorbates. - Google Patents

Verfahren zur herstellung eines ranitidin-harzabsorbates.

Info

Publication number
ATE99925T1
ATE99925T1 AT90312263T AT90312263T ATE99925T1 AT E99925 T1 ATE99925 T1 AT E99925T1 AT 90312263 T AT90312263 T AT 90312263T AT 90312263 T AT90312263 T AT 90312263T AT E99925 T1 ATE99925 T1 AT E99925T1
Authority
AT
Austria
Prior art keywords
resin
ranitidine
absorbate
preparing
adsorbate
Prior art date
Application number
AT90312263T
Other languages
English (en)
Inventor
Stephen John Douglas
Fiona Ruth Bird
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE99925T1 publication Critical patent/ATE99925T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Phenolic Resins Or Amino Resins (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Furan Compounds (AREA)
AT90312263T 1989-11-10 1990-11-09 Verfahren zur herstellung eines ranitidin-harzabsorbates. ATE99925T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898925484A GB8925484D0 (en) 1989-11-10 1989-11-10 Process
EP90312263A EP0431759B1 (de) 1989-11-10 1990-11-09 Verfahren zur Herstellung eines Ranitidin-Harz-Absorbates

Publications (1)

Publication Number Publication Date
ATE99925T1 true ATE99925T1 (de) 1994-01-15

Family

ID=10666117

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90312263T ATE99925T1 (de) 1989-11-10 1990-11-09 Verfahren zur herstellung eines ranitidin-harzabsorbates.

Country Status (9)

Country Link
EP (1) EP0431759B1 (de)
JP (1) JPH03206037A (de)
AT (1) ATE99925T1 (de)
AU (1) AU6652790A (de)
CA (1) CA2029667A1 (de)
DE (1) DE69005993T2 (de)
DK (1) DK0431759T3 (de)
ES (1) ES2047864T3 (de)
GB (1) GB8925484D0 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104042D0 (en) * 1991-02-26 1991-04-10 Abbott Lab Taste-masked buflomedil preparation
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
EP1467769B1 (de) * 2002-01-18 2008-05-28 Rohm and Haas Company Verwendung eines resinats zur herstellung einer formulierung zur beendigung des rauchens
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB838952A (en) * 1957-10-03 1960-06-22 Clinical Products Ltd Resin-drug compounds
FR1335502A (fr) * 1960-06-02 1963-08-23 Merck & Co Inc Nouveaux composés d'adsorption de la nicotinamide
DE2246037B2 (de) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Peroral anwendbares Arzneimittel mit verzögerter Resorbierbarkeit in Suspensionsform
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
GB8629781D0 (en) * 1986-12-12 1987-01-21 Glaxo Group Ltd Pharmaceutical compositions
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it

Also Published As

Publication number Publication date
EP0431759B1 (de) 1994-01-12
EP0431759A1 (de) 1991-06-12
JPH03206037A (ja) 1991-09-09
ES2047864T3 (es) 1994-03-01
AU6652790A (en) 1991-05-16
CA2029667A1 (en) 1991-05-11
GB8925484D0 (en) 1989-12-28
DK0431759T3 (da) 1994-02-28
DE69005993D1 (de) 1994-02-24
DE69005993T2 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
DE69022454D1 (de) Verfahren zur Herstellung eines Polyborosilazanes.
DE69015226D1 (de) Verfahren zur Herstellung eines Fluororganopolysiloxans.
ATE116003T1 (de) Verfahren zur herstellung und reinigung von bernsteinsäure.
ATE24658T1 (de) Verfahren zur herstellung eines molkeproduktes.
DE69201959T2 (de) Verfahren zur Herstellung von 6,12-Dihydro-6-hydroxy-cannabidiol und dessen Anwendung zur Herstellung von trans-delta-9-Tetrahydrocannabinol.
ATE135577T1 (de) Verwendung von buspiron zur herstellung eines pharmazeutischen präparats zur behandlung der alkoholsucht
ATE122054T1 (de) Verfahren zur herstellung eines intravenös verträglichen immunglobulin-g-präparates.
DE59005902D1 (de) Verfahren zur Herstellung niederer, mehrwertiger Alkohole.
DE68913817D1 (de) Verfahren zur Herstellung einer dem Kefir ähnlichen Sauermilch.
DE69030342D1 (de) Verfahren zur Herstellung eines Azadirachtinsamenextrakts mit verbesserter Lagerungsbeständigkeit
EP0391393A3 (de) Verfahren zur Herstellung von Cefodizim-Dinatrium
DE68902575T2 (de) Verfahren zur herstellung von dihydroxybenzolen.
DE69011880D1 (de) Verfahren zur Herstellung von L-Aminosäuren durch Fermentation.
ATE116541T1 (de) Verfahren zur herstellung mikronisierter bioabbaubarer partikel.
DE69016840D1 (de) Verfahren zur Herstellung eines lateralen Bipolartransistors.
DE68923260T2 (de) Verfahren zur Herstellung eines Derivates der 3,5,6-Trihydroxyhexansäure.
DE69217913D1 (de) Verfahren zur Aromatisierung von Milchschokolade
DE59004655D1 (de) Verfahren zur Herstellung eines poly-1-olefins.
ATE99925T1 (de) Verfahren zur herstellung eines ranitidin-harzabsorbates.
DE69009682T2 (de) Verfahren zur Herstellung von Cyclohexanolderivaten.
DE68917709T2 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
DE69008547D1 (de) Verfahren zur Herstellung eines aromatischen Alkohols.
ATE94901T1 (de) Verfahren zur herstellung eines macerierenden aspergillus-enzyms.
DE69017570T2 (de) Verfahren zur Herstellung eines Lactons.
DE68908843D1 (de) Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee